FAZ-053 is a human monoclonal antibody (mAb) that targets B7-H1/PD-L1/CD274. It inhibits the interaction of PD-L1 with PD-1 and B7-1 on monocytes, dendritic cells, and B cells. Additionally, FAZ-053 enhances the production of interleukin-2 and is applicable in research studies on advanced alveolar soft part sarcoma (ASPS), chordoma, and triple-negative breast cancer.
Target:
PD-1/PD-L1
* VAT and and shipping costs not included. Errors and price changes excepted
